glp-1 companion app startups funding research2guidance GLP-1 Companion Products Market Size
Description
Gut function drives whole-body balance

In November 2025, the Trump administration announced landmark agreements with Eli Lilly and Novo Nordisk reducing the monthly price of GLP-1 weight-loss drugs from over $1,000 to as low as $245 for eligible patients

Some Aetna plans may cover Wegovy for weight loss, but it will depend on your plans prescription coverage and your specific diagnosis.

A new FDA-approved obesity pill could offer a lower-cost alternative to injectable GLP-1 drugs like Ozempic and Mounjaro

GLP-2 (Tirzepatide) is a dual incretin receptor agonist widely utilized in preclinical research involving metabolic regulation, incretin signaling, and energy balance-associated biochemical pathways
